PL336262A1 - 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidine compounds - Google Patents

6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidine compounds

Info

Publication number
PL336262A1
PL336262A1 PL98336262A PL33626298A PL336262A1 PL 336262 A1 PL336262 A1 PL 336262A1 PL 98336262 A PL98336262 A PL 98336262A PL 33626298 A PL33626298 A PL 33626298A PL 336262 A1 PL336262 A1 PL 336262A1
Authority
PL
Poland
Prior art keywords
aminopyrido
disubstituted
pyrimidine compounds
pyrimidine
compounds
Prior art date
Application number
PL98336262A
Inventor
Shripad S Bhagwat
Chih-Hung Lee
Richard J Perner
Yu-Gui Gu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PL336262A1 publication Critical patent/PL336262A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
PL98336262A 1997-04-16 1998-04-16 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidine compounds PL336262A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83439397A 1997-04-16 1997-04-16
PCT/US1998/004127 WO1998046603A1 (en) 1997-04-16 1998-04-16 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds

Publications (1)

Publication Number Publication Date
PL336262A1 true PL336262A1 (en) 2000-06-19

Family

ID=25266829

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98336262A PL336262A1 (en) 1997-04-16 1998-04-16 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidine compounds

Country Status (20)

Country Link
EP (1) EP0979230A1 (en)
JP (1) JP2001520649A (en)
KR (1) KR20010006453A (en)
CN (1) CN1259948A (en)
AR (1) AR012435A1 (en)
AU (1) AU744528B2 (en)
BG (1) BG103861A (en)
BR (1) BR9809088A (en)
CA (1) CA2287465A1 (en)
CO (1) CO4940439A1 (en)
HU (1) HUP0001402A3 (en)
IL (1) IL131892A0 (en)
NO (1) NO995033L (en)
NZ (1) NZ337844A (en)
PL (1) PL336262A1 (en)
SK (1) SK142099A3 (en)
TR (1) TR199902456T2 (en)
TW (1) TW458977B (en)
WO (1) WO1998046603A1 (en)
ZA (1) ZA982912B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
HU229604B1 (en) * 2001-02-12 2014-02-28 Hoffmann La Roche 6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them
WO2006053250A2 (en) 2004-11-12 2006-05-18 Trustees Of Tufts College Lipase inhibitors
US20100063032A1 (en) * 2007-03-28 2010-03-11 Debenham John S Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
EA201590693A1 (en) * 2012-10-05 2015-08-31 Ригель Фармасьютикалс, Инк. INHIBITORS GDF-8
US10016432B2 (en) 2016-05-27 2018-07-10 Legacy Emanuel Hospital & Health Center Methanocarba derivatives of pseudoribose that inhibit adenosine kinase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
CO4940439A1 (en) 2000-07-24
BG103861A (en) 2000-06-30
NO995033D0 (en) 1999-10-15
IL131892A0 (en) 2001-03-19
TR199902456T2 (en) 2000-07-21
ZA982912B (en) 1998-10-09
AU744528B2 (en) 2002-02-28
CA2287465A1 (en) 1998-10-22
JP2001520649A (en) 2001-10-30
CN1259948A (en) 2000-07-12
NO995033L (en) 1999-12-15
KR20010006453A (en) 2001-01-26
EP0979230A1 (en) 2000-02-16
NZ337844A (en) 2001-11-30
BR9809088A (en) 2000-08-01
WO1998046603A1 (en) 1998-10-22
SK142099A3 (en) 2000-05-16
AR012435A1 (en) 2000-10-18
HUP0001402A3 (en) 2001-01-29
TW458977B (en) 2001-10-11
AU7098198A (en) 1998-11-11
HUP0001402A2 (en) 2000-10-28

Similar Documents

Publication Publication Date Title
IL139598A0 (en) PYRROLO [2,3-d] PYRIMIDINE COMPOUNDS
IL139586A0 (en) PYRROLO [2,3-d] PYRIMIDINE COMPOUNDS
EG24399A (en) Pyrrolo[2,3-D]pyrimidine compounds
HK1078574A1 (en) Pyrazolo [4,3-D] pyrimidine derivatives
IL125358A0 (en) 5H-thiazolo [3,2-a] pyrimidine derivatives
CZ20011962A3 (en) Novel triazolo[4,5-d]pyrimidine compounds
AP9901632A0 (en) Pyrazine compounds
PL353366A1 (en) Pyrazolo[4,3-d]pyrimidines
ZA983177B (en) 5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds
PL336262A1 (en) 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidine compounds
IL136500A0 (en) 1,4-diazacycloheptane derivatives
PL336265A1 (en) 5,6,7-trisubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
EP0904271A4 (en) 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES
ZA994004B (en) Pyrrolo[2,3-d]pyrimidine compounds.
SI1087970T1 (en) PYRROLO 2,3-d)PYRIMIDINE COMPOUNDS
SI1210349T1 (en) PYRAZOLO 4,3-d)PYRIMIDINES
AU3500997A (en) 5,6,7,8-tetrahydropyrido{2,3-d}pyrimidine derivatives